TMune Therapeutics' Secondary Market Round

TMune Therapeutics raised a round of funding on January 02, 2012. Investors include Biomark Capital.

TMune Therapeutics is a biotechnology company.…

Articles about TMune Therapeutics' Secondary Market Round: